China National Accord Medicines Corporation Ltd. (200028.SZ)
200028.SZ Stock Price Chart
Explore China National Accord Medicines Corporation Ltd. interactive price chart. Choose custom timeframes to analyze 200028.SZ price movements and trends.
200028.SZ Company Profile
Discover essential business fundamentals and corporate details for China National Accord Medicines Corporation Ltd. (200028.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
10 Aug 1993
Employees
39.45K
Website
https://www.szaccord.com.cnCEO
Zhaoxiong Lin MBA
Description
China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.
200028.SZ Financial Timeline
Browse a chronological timeline of China National Accord Medicines Corporation Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
Dividend declared on 25 Jun 2025
A dividend of $0.40 per share was announced, adjusted to $0.40. The dividend was paid on 27 Jun 2025.
Earnings released on 25 Apr 2025
EPS came in at $0.63 falling short of the estimated $0.65 by -3.67%, while revenue for the quarter reached $19.52B , missing expectations by -11.31%.
Earnings released on 31 Dec 2024
EPS came in at -$0.81 falling short of the estimated $0.71 by -212.98%, while revenue for the quarter reached $19.05B , missing expectations by -35.11%.
Earnings released on 28 Oct 2024
EPS came in at $0.64 falling short of the estimated $0.69 by -6.84%, while revenue for the quarter reached $20.67B , missing expectations by -21.95%.
Earnings released on 28 Aug 2024
EPS came in at $0.68 surpassing the estimated $0.68 by +1.03%, while revenue for the quarter reached $20.08B , missing expectations by -15.34%.
Dividend declared on 25 Jun 2024
A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 27 Jun 2024.
Earnings released on 25 Apr 2024
EPS came in at $0.76 falling short of the estimated $0.80 by -5.61%, while revenue for the quarter reached $20.65B , missing expectations by -0.16%.
Earnings released on 29 Feb 2024
EPS came in at $0.81 surpassing the estimated $0.69 by +17.17%, while revenue for the quarter reached $20.91B , missing expectations by -14.47%.
Earnings released on 26 Oct 2023
EPS came in at $0.70 falling short of the estimated $0.84 by -17.42%, while revenue for the quarter reached $19.52B , missing expectations by -14.46%.
Earnings released on 8 Aug 2023
EPS came in at $1.19 surpassing the estimated $0.85 by +40.00%, while revenue for the quarter reached $21.30B , beating expectations by +0.40%.
Dividend declared on 1 Jun 2023
A dividend of $1.17 per share was announced, adjusted to $0.90. The dividend was paid on 1 Jun 2023.
Stock split effective on 1 Jun 2023
Shares were split 13 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Apr 2023
EPS came in at $1.17 , while revenue for the quarter reached $21.44B .
Earnings released on 12 Apr 2023
EPS came in at $1.03 surpassing the estimated $0.69 by +49.71%, while revenue for the quarter reached $21.33B , beating expectations by +3.81%.
Earnings released on 24 Oct 2022
EPS came in at $0.88 surpassing the estimated $0.83 by +5.77%, while revenue for the quarter reached $20.31B , missing expectations by -8.49%.
Earnings released on 19 Aug 2022
EPS came in at $0.98 surpassing the estimated $0.69 by +41.21%, while revenue for the quarter reached $22.22B , beating expectations by +2.17%.
Dividend declared on 17 Jun 2022
A dividend of $0.73 per share was announced, adjusted to $0.56. The dividend was paid on 21 Jun 2022.
Earnings released on 27 Apr 2022
EPS came in at $0.59 falling short of the estimated $0.68 by -13.62%, while revenue for the quarter reached $21.14B , beating expectations by +10.62%.
Earnings released on 15 Mar 2022
EPS came in at $0.61 , while revenue for the quarter reached $22.22B .
Earnings released on 20 Oct 2021
EPS came in at $0.78 , while revenue for the quarter reached $20.56B .
Earnings released on 17 Aug 2021
EPS came in at $1.16 , while revenue for the quarter reached $20.55B .
Dividend declared on 21 Jun 2021
A dividend of $0.96 per share was announced, adjusted to $0.74. The dividend was paid on 23 Jun 2021.
Earnings released on 24 Apr 2021
EPS came in at $1.13 , while revenue for the quarter reached $19.92B .
Earnings released on 1 Apr 2021
EPS came in at $0.70 , while revenue for the quarter reached $19.01B .
Earnings released on 21 Oct 2020
EPS came in at $0.83 , while revenue for the quarter reached $17.91B .
200028.SZ Stock Performance
Access detailed 200028.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.